Members
The American Heart Association is a relentless force for a world of longer, healthier lives. The Dallas-based organization is dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, the American Heart Association funds innovative research, advocates for the public’s health and shares lifesaving resources.
The American Society for Microbiology (ASM), originally the Society of American Bacteriologists, is a professional organization for scientists who study viruses, bacteria, fungi, algae, and protozoa as well as other aspects of microbiology. It was founded in 1899. The Society publishes a variety of scientific journals, textbooks, and other educational materials related to microbiology and infectious diseases. ASM organizes annual meetings, as well as workshops and professional development opportunities for its members.
The Association of Immunization Managers (AIM) is dedicated to establishing a nation free of vaccine-preventable disease. AIM members are the leaders of state, local, and territorial immunization programs—directing the public health efforts designed to keep children and adults vaccinated and protected against disease. Since 1999, AIM has provided a national voice for immunization programs and a forum for program managers to learn from each other, confront challenges, and achieve success. Since its inception, AIM has gathered and shared information with its members on policy implementation, legislative issues, programmatic successes, and more.
The Association of Public Health Laboratories (APHL) works to strengthen laboratory systems serving the public’s health in the United States and globally. APHL represents state and local governmental health laboratories in the United States; this includes public health, agricultural, environmental, and other related laboratories. Its members, known collectively as “public health laboratories,” monitor, detect and respond to health threats
The Association of State and Territorial Health Officials (ASTHO) represents the public health agencies of all 50 states in the United States, the District of Columbia, the five U.S. territories, and the three freely associated states. ASTHO members, the chief health officials in each of these jurisdictions, formulate and influence public health policy and work to protect and promote good health in the populations they serve.
Founded in 1953, AAFA is the oldest and largest non-profit patient organization dedicated to saving lives and reducing the burden of disease for people with asthma, allergies and related conditions through research, education, advocacy and support. AAFA offers extensive support for individuals and families affected by asthma and allergic diseases, such as food allergies and atopic dermatitis (eczema). Through its online patient support communities, network of local chapters and affiliated support groups, AAFA empowers patients and their families by providing practical, evidence-based information and community programs and services. AAFA is the only asthma and allergy patient advocacy group that is certified to meet the standards of excellence set by the National Health Council. For more information, visit aafa.org and kidswithfoodallergies.org.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 125 countries, and its innovative medicines are used by millions of patients worldwide.
For more information, please visit www.astrazeneca-us.com and follow us on social media @AstraZeneca.
BD is one of the largest global medical technology companies in the world and is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of healthcare by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for healthcare providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics.
Blueprint Biosecurity is a nonprofit dedicated to ending pandemics. We do this by first creating detailed and practical plans for accelerating the development of pandemic prevention technologies and policies. We then work with partners across government, academia, and industry to put those plans into action. We believe that a world without pandemics also means a world without the flu.
Centivax, a leader in universal vaccine development, is working to eliminate the threat of seasonal and pandemic influenza through its universal flu vaccine, Centi-Flu. Notably, animals immunized with Centi-Flu produced broad neutralizing titers and robust cellular immunity that spans over a century’s worth of influenza strains, including those not in the vaccine itself—including neutralizing antibody titers and T-cell responses against the currently circulating H5N1 pandemic strain. Centivax’s goal is to protect people of all ages and regions from influenza, end the pandemic era, and ultimately usher in a world free from the burden of flu.
As one of the largest influenza vaccine providers in the world, CSL Seqirus is a major contributor to the prevention of influenza globally and a transcontinental partner in pandemic preparedness. CSL Seqirus operates state-of-the-art production facilities in the U.S., the UK and Australia, and manufactures influenza vaccines using both egg-based and cell-based technologies. It has leading R&D capabilities, a broad portfolio of differentiated products and a commercial presence in more than 20 countries.
Founded in 2004, Families Fighting Flu (FFF) is a national, nonprofit, 501(c)(3) advocacy organization dedicated to protecting children, families, and communities against the flu. The organization includes families whose loved ones have suffered serious medical complications or died from influenza, as well as other advocates and healthcare professionals committed to flu education and prevention.
Founded more than 40 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit http://www.gene.com.
GSK is a science-led global healthcare company with a special purpose to help people do more,
feel better, live longer.We have three global businesses that discover, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products. We are the world’s largest vaccines company*, delivering vaccines that help protect people at all stages of life. Our R&D focuses on developing vaccines against infectious diseases that combine high medical need and strong market potential. Every day, we help improve the health of millions of people around the world.Our goal is to become one of the world’s most innovative, best performing and trusted healthcare companies. Learn more: https://www.gsk.com
* world’s largest vaccines company by revenue
GHIC, a nonprofit organization, has been investing in global health innovation for over a decade. Through investments in life sciences and healthcare technology companies, we accelerate the development and accessibility of products with the potential to improve global public health and health equity, and generate sustainable financial returns.
The Healthcare Distribution Alliance (HDA) represents primary pharmaceutical distributors — the vital link between the nation’s pharmaceutical manufacturers and pharmacies, hospitals, long-term care facilities, clinics and others nationwide. Since 1876, HDA has helped members navigate regulations and innovations to get the right medicines to the right patients at the right time, safely and efficiently. The HDA Research Foundation, HDA’s nonprofit charitable foundation, serves the healthcare industry by providing research and education focused on priority healthcare supply chain issues.
IDBiologics is a private biopharmaceutical company focused on the discovery and development of human monoclonal antibodies (mAbs) for the prevention and treatment of infectious diseases. IDBiologics is developing a clinical candidate to address both seasonal (H1 and H3) and pre-pandemic strains of influenza (H5, H7, H9). Beyond Pan-Influenza (seasonal prophylaxis against Flu A & B), the Company’s pipeline includes clinical lead mAbs targeting the BK virus, Respiratory Syncytial virus / metapneumovirus combination (RSV/MPV), Zika virus, Rift Valley Fever virus and Enterovirus D68. The Company has a sponsored research agreement with its co-founder, Dr. James E. Crowe, and his laboratory at the Vanderbilt University Medical Center (VUMC). Our innovative fully human mAb platform enables rapid discovery and optimization of broad and potent mAbs with neutralizing activity to a range of viral targets.
The Infectious Diseases Society of America (IDSA) is a community of over 12,000 physicians, scientists and public health experts who specialize in infectious diseases. Our mission is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.
Immunize.org, formerly The Immunization Action Coalition (IAC), works to increase immunization rates and prevent disease by creating and distributing educational materials for healthcare professionals and the public that enhance the delivery of safe and effective immunization services. Immunize.org also facilitates communication about the safety, efficacy, and use of vaccines within the broad immunization community of patients, parents, healthcare organizations, and government health agencies.
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna’s mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines.
NACCHO is the only organization dedicated to serving every local health department in the nation. NACCHO serves 3000 local health departments and is the leader in providing cutting-edge, skill-building, professional resources and programs, seeking health equity, and supporting effective local public health practice and systems.
Founded in 1973, the National Foundation for Infectious Diseases (NFID) is a non-profit 501(c)(3) organization dedicated to educating the public and healthcare professionals about the burden, causes, prevention, diagnosis, and treatment of infectious diseases across the lifespan. Our vision: Healthier lives through effective prevention and treatment of infectious diseases. Our mission: Educate the public and healthcare professionals about the burden, causes, prevention, diagnosis, and treatment of infectious diseases across the lifespan.
Launched in 1987 during the early years of the HIV/AIDS crisis, NMAC is a national HIV organization that offers capacity building, leadership development, policy education, and digital engagement to end the HIV epidemic among communities most impacted in the United States. We convene the Biomedical HIV Prevention Summit – the nation’s largest gathering of the public health workforce focused on enhancing PrEP for HIV prevention and the U.S. Conference on HIV/AIDS – the nation’s largest gathering for community mobilization and workforce development
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us.
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Sanofi, Empowering Life
Trust for America’s Health is a non-partisan public health policy, research and advocacy organization that envisions a nation that values the health and well-being of all and where prevention and health equity are foundational to policymaking at all levels of society
Vaccinate Your Family (VYF) is a national nonprofit organization that strives to protect people of all ages from vaccine-preventable diseases by:
- Raising awareness of the critical need for timely immunizations
- Increasing the public’s understanding of the benefits of vaccines
- Increasing confidence in the safety of vaccines
- Ensuring that all families have access to lifesaving vaccines
- Advocating for policies that support timely vaccination